GlassScriptPhysician profile
Bradley James Kasper
NPI 1720582778
$1,360.96
in general payments reported to CMS, 2019-2025
17 companies · $200 in 2025
The $200 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.62 · 2020: $19.94 · 2021: $39.60 · 2022: $146 · 2023: $752 · 2024: $188 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $877 · Education: $264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $876.60 |
| Education | $263.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $322.71 | 2023 | Veozah |
| Baxter Healthcare | $251.08 | 2024-2025 | Tisseel |
| Myriad Women'S Health, INC. | $169.43 | 2023 | Myrisk |
| Hologic Sales and Service, LLC | $114.29 | 2023 | Novasure |
| Abbvie INC. | $75.23 | 2021-2023 | |
| Organon LLC | $66.23 | 2022-2025 | |
| Ethicon US, LLC | $59.99 | 2023-2025 | Stratafix, Enseal, Vistaseal |
| Biogen, INC. | $55.12 | 2025 | Zurzuvae |
| Agile Therapeutics, INC. | $44.78 | 2023 | Twirla |
| Mayne Pharma Commercial LLC | $40.81 | 2022-2023 | |
| Therapeuticsmd, INC. | $39.08 | 2020-2022 | |
| Daiichi Sankyo INC. | $36.49 | 2022-2023 | Injectafer |
| Millicent US INC | $24.50 | 2024 | Intrarosa |
| Evofem Biosciences, INC. | $19.46 | 2022 | |
| Merck Sharp & Dohme LLC | $14.62 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $13.64 | 2023 | Balcoltra |
| Alfasigma USA, INC. | $13.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Kasper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.